Actively Recruiting

Age: 18Years +
All Genders
ID06248944

AIOCC Italian Registry on Head and Neck Carcinomas

Led by Italian Head&Neck Society · Updated on 2024-03-08

7000

Participants Needed

7

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting detailed information on patients with carcinoma of the Head and Neck through a multicenter registry in Italy. This observational study combines both retrospective and prospective data collection to better understand how this cancer is diagnosed and treated. The goal is to support further research and collaborations by creating a comprehensive database of patient and disease characteristics. Data is gathered by healthcare professionals at participating Italian sites, who manually enter patient information into an electronic case report form. The study uses a secure system called Vantage6 to analyze data while protecting patient privacy. This registry includes patients at any disease stage and will collect information from diagnosis through treatment and follow-up. Participants contribute by allowing their clinical data to be included in the registry. Researchers will review diagnostic methods, treatment patterns, disease stages, outcomes, healthcare use, and other factors over a five-year period. The study aims to provide benchmark values and identify prognostic factors, supporting both local and international observational studies on head and neck cancer.

CONDITIONS

Brief Title

AIOCC Italian Registry on Head and Neck Carcinomas

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients aged 18 years or older diagnosed with carcinoma of the Head and Neck verified by an expert site
  • Patients at any clinical phase of the disease, including diagnosis, primary treatment, recurrence, or metastatic treatment
  • New patients managed from 2021 onwards and patients in active follow-up at participating sites
Not Eligible

You will not qualify if you...

  • Patients diagnosed with sarcomas or lymphomas
  • Patients whose medical records are not available for review

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) to confirm eligibility

Surveillance

Duration - Up to 5 years

Participants who undergo routine care for Head and Neck cancer are observed to collect data on their diagnosis, treatment, and outcomes.

Data collected during regular clinical visits as part of routine care

Trial Site Locations

Total: 7 locations

1

Fondazione del Piemonte per l'Oncologia - IRCCS

Candiolo, Italy

Actively Recruiting

2

A.O.U. Careggi

Florence, Italy

Actively Recruiting

3

P.O. 'Vito Fazzi'

Lecce, Italy

Actively Recruiting

4

Fondazione IRCCS Istituto Nazionale Tumori

Milan, Italy, 20133

Actively Recruiting

5

Fondazione CNAO

Pavia, Italy

Actively Recruiting

6

Fondazione Policlinico Universitario 'Agostino Gemelli' IRCCS

Roma, Italy

Actively Recruiting

7

Azienda Ospedaliera Universitaria Integrata di Verona

Verona, Italy

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Financial Compass: A Pilot Feasibility Study of a Novel Inte...

Head and Neck Carcinoma

Actively Recruiting

1 location

Radiation De-Escalation Pilot Study for p16-Negative Orophar...

Head and Neck Cancer

Actively Recruiting

6 locations

Accelerator-based Boron Neutron Capture Therapy (BNCT) in th...

Head and Neck Carcinoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here